Source: BioPortfolio

Exscientia: Celgene and Exscientia sign $25 million AI drug discovery deal

Celgene a USbased global biotech company has entered into a $25 million threeyear partnership with UKbased Exscientia which specialises in...Read More...The post Celgene and Exscientia sign $25 million AI drug discovery deal appeared first on Pharmaceutica...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Andrew Hopkins's photo - Founder & CEO of Exscientia

Founder & CEO

Andrew Hopkins

CEO Approval Rating

81/100

Read more